×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

. (ARIA)

$23.99 - (-)

Market Cap: -

As of 07/22/19 12:00 AM EDT. Market closed.

(ARIA)

. (ARIA)

$23.99
- (-)

Market Cap: -

As of 07/22/19 12:00 AM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$23.99
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$23.99
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Cole Hugh MSVP, Chief Business OfficerJun 25, 2015 Option Exercise$8.696,24954,30442,834Feb 07, 2017, 04:59 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJan 31, 2017 Option Exercise$23.8114,667349,293126,352Feb 02, 2017, 04:42 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJan 31, 2017 Option Exercise$23.829,610228,886219,867Feb 02, 2017, 04:41 PM
Panayiotopoulos ParisPresident and CEOJan 17, 2017 Option Exercise$23.6933,300788,934159,378Jan 17, 2017, 05:06 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJan 09, 2017 Option Exercise$7.8232,000250,240161,404Jan 10, 2017, 06:17 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJan 09, 2017 Sale$23.7832,000760,960129,404Jan 10, 2017, 06:17 PM
CLACKSON TIMOTHY PPresident, R&D, CSOOct 24, 2016 Sale$9.5619,638187,739197,884Oct 25, 2016, 04:07 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityOct 03, 2016 Sale$13.4647,384637,812129,404Oct 05, 2016, 04:17 PM
CLACKSON TIMOTHY PPresident, R&D, CSOSep 28, 2016 Sale$13.988,750122,311217,522Sep 28, 2016, 04:19 PM
CLACKSON TIMOTHY PPresident, R&D, CSOSep 22, 2016 Sale$13.4320,000268,536208,772Sep 23, 2016, 05:46 PM
CLACKSON TIMOTHY PPresident, R&D, CSOSep 15, 2016 Option Exercise$7.8259,369464,266288,141Sep 16, 2016, 05:08 PM
CLACKSON TIMOTHY PPresident, R&D, CSOSep 15, 2016 Sale$11.7359,369696,398228,772Sep 16, 2016, 05:08 PM
CLACKSON TIMOTHY PPresident, R&D, CSOAug 22, 2016 Sale$10.4719,436203,538228,772Aug 23, 2016, 04:12 PM
CLACKSON TIMOTHY PPresident, R&D, CSOAug 12, 2016 Option Exercise$7.6925,000192,250273,208Aug 15, 2016, 04:16 PM
CLACKSON TIMOTHY PPresident, R&D, CSOAug 12, 2016 Sale$10.5025,000262,500248,208Aug 15, 2016, 04:16 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 22, 2016 Sale$8.1118,286148,230248,208Jul 25, 2016, 04:39 PM
Panayiotopoulos ParisPresident and CEOJul 13, 2016 Option Exercise$7.1428,611204,283126,078Jul 14, 2016, 04:23 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 01, 2016 Option Exercise$3.8861,422238,585297,916Jul 05, 2016, 04:07 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 01, 2016 Sale$7.4861,422459,634266,494Jul 05, 2016, 04:07 PM
Cole Hugh MSVP, Chief Business OfficerJun 28, 2016 Sale$7.056,01242,38529,916Jun 29, 2016, 04:25 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJun 22, 2016 Sale$7.2823,999174,638264,742Jun 23, 2016, 04:11 PM
LAVIDAS ATHANESEDirectorJun 15, 2016 Option Exercise$6.5546,250302,787177,881Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESEDirectorJun 14, 2016 Option Exercise$6.4420,000128,800151,631Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESEDirectorJun 13, 2016 Option Exercise$5.4910,00054,900141,631Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESEDirectorJun 15, 2016 Sale$8.2446,250381,137131,631Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESEDirectorJun 14, 2016 Sale$8.1420,000162,852131,631Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESEDirectorJun 13, 2016 Sale$8.2010,00082,050131,631Jun 15, 2016, 04:19 PM
Radaelli MassimoDirectorJun 14, 2016 Option Exercise$4.916,25030,687111,750Jun 14, 2016, 06:13 PM
Radaelli MassimoDirectorJun 13, 2016 Option Exercise$6.5779,731523,551185,231Jun 14, 2016, 06:13 PM
Radaelli MassimoDirectorJun 10, 2016 Option Exercise$1.3522,58830,494128,088Jun 14, 2016, 06:13 PM
Radaelli MassimoDirectorJun 13, 2016 Sale$8.2579,731657,821105,500Jun 14, 2016, 06:13 PM
Radaelli MassimoDirectorJun 10, 2016 Sale$8.3022,588187,480105,500Jun 14, 2016, 06:13 PM
Radaelli MassimoDirectorJun 14, 2016 Sale$8.136,25050,834105,500Jun 14, 2016, 06:13 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMay 23, 2016 Sale$8.0817,762143,430288,741May 25, 2016, 04:04 PM
Panayiotopoulos ParisPresident and CEOMay 12, 2016 Buy$7.4126,990199,99688,089May 13, 2016, 05:59 PM
Haluska FrankSVP, Clinical R&D, CMOApr 29, 2016 Option Exercise$7.185,63440,452158,711May 02, 2016, 05:33 PM
Cantor Maria ESVP, Corporate AffairsApr 29, 2016 Option Exercise$7.184,33431,118144,667May 02, 2016, 05:32 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityApr 29, 2016 Option Exercise$7.185,63440,452166,788May 02, 2016, 05:30 PM
Cole Hugh MSVP, Chief Business OfficerApr 29, 2016 Option Exercise$7.185,63440,45216,762May 02, 2016, 05:29 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMay 02, 2016 Sale$7.1311,70083,478306,503May 02, 2016, 05:28 PM
Duvall Martin JEVP, CCOApr 29, 2016 Option Exercise$7.185,85042,003105,189May 02, 2016, 05:26 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 22, 2016 Sale$7.3721,409157,864294,803Apr 25, 2016, 04:04 PM
DesRosier ThomasEVP, General CounselFeb 18, 2016 Option Exercise$5.0318,37092,40136,630Mar 30, 2016, 05:04 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 22, 2016 Sale$6.5823,834156,871316,212Mar 23, 2016, 04:41 PM
Duvall Martin JEVP, CCOMar 19, 2016 Sale$6.474,00025,86793,039Mar 22, 2016, 04:03 PM
BERSTEIN DAVID LSVP, Chief IP CounselMar 21, 2016 Sale$6.472,37515,356262,115Mar 22, 2016, 04:02 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 21, 2016 Sale$6.474,00025,871155,088Mar 22, 2016, 04:02 PM
Cantor Maria ESVP, Corporate AffairsMar 19, 2016 Sale$6.463,57523,102135,667Mar 22, 2016, 04:02 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 19, 2016 Sale$6.475,41735,039340,046Mar 22, 2016, 04:01 PM
FITZGERALD EDWARD MExecutive VPMar 21, 2016 Sale$6.475,41735,037320,367Mar 22, 2016, 04:01 PM
Haluska FrankSVP, Clinical R&D, CMOMar 21, 2016 Sale$6.473,57523,116147,011Mar 22, 2016, 04:01 PM
Cole Hugh MSVP, Chief Business OfficerMar 16, 2016 Option Exercise$6.212,43815,1405,062Mar 18, 2016, 04:04 PM
Cole Hugh MSVP, Chief Business OfficerMar 16, 2016 Option Exercise$6.217,50046,5757,500Mar 18, 2016, 04:04 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 15, 2016 Option Exercise$6.1822,814141,009132,024Mar 17, 2016, 04:45 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 15, 2016 Option Exercise$1.303,7504,875154,838Mar 17, 2016, 04:45 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 03, 2016 Sale$6.129,62558,866314,951Mar 03, 2016, 08:12 PM
BERSTEIN DAVID LSVP, Chief IP CounselMar 03, 2016 Sale$6.129,62558,887259,740Mar 03, 2016, 08:08 PM
Duvall Martin JEVP, CCOMar 03, 2016 Sale$6.129,62558,86389,039Mar 03, 2016, 08:07 PM
Cantor Maria ESVP, Corporate AffairsMar 03, 2016 Sale$6.129,62558,869132,742Mar 03, 2016, 08:00 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 02, 2016 Sale$6.0025,047150,282344,255Mar 03, 2016, 08:00 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 03, 2016 Sale$6.129,62558,867334,630Mar 03, 2016, 08:00 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 03, 2016 Sale$6.119,62558,852151,088Mar 03, 2016, 07:59 PM
Haluska FrankSVP, Clinical R&D, CMOMar 03, 2016 Sale$6.1110,58864,733144,086Mar 03, 2016, 07:58 PM
Panayiotopoulos ParisPresident and CEOFeb 01, 2016 Buy$4.9161,099299,99661,099Feb 03, 2016, 05:43 PM
Duvall Martin JEVP, CCOFeb 01, 2016 Sale$4.8114,66770,57879,414Feb 03, 2016, 04:46 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 01, 2016 Sale$4.8114,66770,517350,052Feb 03, 2016, 04:43 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityFeb 01, 2016 Sale$4.8114,66770,548141,463Feb 03, 2016, 04:41 PM
Haluska FrankSVP, Clinical R&D, CMOFeb 01, 2016 Sale$4.8116,13377,587135,424Feb 03, 2016, 04:39 PM
BERSTEIN DAVID LSVP, Chief IP CounselFeb 01, 2016 Sale$4.8114,66770,515250,115Feb 03, 2016, 04:38 PM
FITZGERALD EDWARD MExecutive VP, CFOFeb 01, 2016 Sale$4.8114,66770,515305,326Feb 03, 2016, 04:37 PM
Cantor Maria ESVP, Corporate AffairsFeb 01, 2016 Sale$4.8216,13377,745137,784Feb 03, 2016, 04:35 PM
BERGER HARVEY J M DChairman & CEODec 31, 2015 Option Exercise$6.25284,3811,777,3811,732,111Jan 05, 2016, 05:41 PM
BERSTEIN DAVID LSVP, Chief IP CounselSep 28, 2015 Sale$6.465,00032,315235,449Sep 30, 2015, 04:14 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 28, 2015 Sale$6.465,00032,315126,797Sep 28, 2015, 06:35 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 28, 2015 Sale$6.465,00032,315126,797Sep 28, 2015, 06:14 PM
Duvall Martin JEVP, CCOSep 28, 2015 Sale$6.465,00032,31764,748Sep 28, 2015, 06:09 PM
Cantor Maria ESVP, Corporate AffairsSep 28, 2015 Sale$6.475,00032,327109,917Sep 28, 2015, 05:57 PM
FITZGERALD EDWARD MExecutive VP, CFOSep 28, 2015 Sale$6.468,75056,551289,231Sep 28, 2015, 05:50 PM
Haluska FrankSVP, Clinical R&D, CMOSep 28, 2015 Sale$6.455,50035,502122,224Sep 28, 2015, 05:40 PM
CLACKSON TIMOTHY PPresident, R&D, CSOSep 28, 2015 Sale$6.468,75056,560334,086Sep 28, 2015, 05:36 PM
BERSTEIN DAVID LSVP, Chief IP CounselSep 28, 2015 Sale$6.465,00032,315240,449Sep 28, 2015, 05:02 PM
Cantor Maria ESVP, Corporate AffairsSep 01, 2015 Sale$9.112,69624,557104,917Sep 03, 2015, 04:20 PM
FITZGERALD EDWARD MExecutive VP, CFOAug 28, 2015 Sale$10.0032,858328,580280,481Sep 01, 2015, 05:14 PM
Cantor Maria ESVP, Corporate AffairsAug 28, 2015 Sale$10.001,26812,680107,613Sep 01, 2015, 05:14 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 16, 2015 Sale$8.547,00059,797325,336Jul 16, 2015, 05:40 PM
Duvall Martin JEVP, CCOJul 16, 2015 Sale$8.541,40011,95659,748Jul 16, 2015, 05:34 PM
FITZGERALD EDWARD MExecutive VP, CFOJul 16, 2015 Sale$8.547,00059,793313,339Jul 16, 2015, 05:25 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJul 16, 2015 Sale$8.544,00034,164121,797Jul 16, 2015, 05:14 PM
Cantor Maria ESVP, Corporate AffairsJul 16, 2015 Sale$8.544,00034,162108,881Jul 16, 2015, 05:12 PM
BERSTEIN DAVID LSVP, Chief IP CounselJul 16, 2015 Sale$8.544,00034,162230,449Jul 16, 2015, 05:10 PM
Haluska FrankSVP, Clinical R&D, CMOJul 16, 2015 Sale$8.544,40037,575117,724Jul 16, 2015, 05:08 PM
BERGER HARVEY J M DChairman & CEOJul 15, 2015 Option Exercise$8.3517,370145,0401,366,492Jul 16, 2015, 04:22 PM
FITZGERALD EDWARD MExecutive VP, CFOMay 01, 2015 Option Exercise$7.5660,000453,600365,852May 04, 2015, 04:36 PM
FITZGERALD EDWARD MExecutive VP, CFOMay 01, 2015 Sale$8.8060,000528,000305,852May 04, 2015, 04:36 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 23, 2015 Sale$9.50123,7661,175,777316,548Apr 27, 2015, 04:14 PM
BERGER HARVEY J M DChairman & CEOMar 26, 2015 Option Exercise$8.17127,1941,039,1751,343,460Mar 30, 2015, 04:21 PM
BERGER HARVEY J M DChairman & CEOMar 26, 2015 Option Exercise$7.56150,0001,134,0001,446,175Mar 30, 2015, 04:21 PM
BERSTEIN DAVID LSVP, Chief IP CounselMar 23, 2015 Sale$8.562,00017,118226,449Mar 23, 2015, 06:26 PM
BERSTEIN DAVID LSVP, Chief IP CounselMar 20, 2015 Sale$8.852,37521,026224,449Mar 23, 2015, 06:26 PM
Cantor Maria ESVP, Corporate Affairs and HRMar 19, 2015 Option Exercise$3.087,87524,255114,504Mar 23, 2015, 06:16 PM
Cantor Maria ESVP, Corporate Affairs and HRMar 23, 2015 Sale$8.554,03334,491104,881Mar 23, 2015, 06:16 PM
Cantor Maria ESVP, Corporate Affairs and HRMar 20, 2015 Sale$8.853,57531,627101,583Mar 23, 2015, 06:16 PM
Cantor Maria ESVP, Corporate Affairs and HRMar 19, 2015 Sale$9.009,34684,114106,629Mar 23, 2015, 06:16 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 23, 2015 Sale$8.553,00025,661117,797Mar 23, 2015, 06:06 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 20, 2015 Sale$8.854,00035,390114,797Mar 23, 2015, 06:06 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 23, 2015 Sale$8.554,16735,630305,209Mar 23, 2015, 06:02 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 20, 2015 Sale$8.845,41747,908301,043Mar 23, 2015, 06:02 PM
Duvall Martin JEVP, CCOMar 23, 2015 Sale$8.578347,14554,950Mar 23, 2015, 05:59 PM
Duvall Martin JEVP, CCOMar 20, 2015 Sale$8.854,00035,38154,117Mar 23, 2015, 05:59 PM
Haluska FrankSVP, Clinical R&D, CMOMar 23, 2015 Sale$8.553,30028,229114,124Mar 23, 2015, 05:54 PM
Haluska FrankSVP, Clinical R&D, CMOMar 20, 2015 Sale$8.853,57531,634111,424Mar 23, 2015, 05:54 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 19, 2015 Option Exercise$7.5620,657156,167460,971Mar 23, 2015, 05:45 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 19, 2015 Sale$9.0020,657185,913440,314Mar 23, 2015, 05:45 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 23, 2015 Sale$8.556,66757,016440,314Mar 23, 2015, 05:45 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 20, 2015 Sale$8.845,41747,910433,648Mar 23, 2015, 05:45 PM
BERSTEIN DAVID LSVP, Chief IP CounselMar 23, 2015 Sale$8.562,00017,118159,907Mar 23, 2015, 05:27 PM
BERSTEIN DAVID LSVP, Chief IP CounselMar 20, 2015 Sale$8.852,37521,026157,907Mar 23, 2015, 05:27 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 16, 2015 Option Exercise$1.307,5009,750145,222Mar 18, 2015, 04:23 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 16, 2015 Sale$8.6234,425296,651137,722Mar 18, 2015, 04:23 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 20, 2015 Option Exercise$3.5449,035173,419453,231Feb 24, 2015, 04:23 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 20, 2015 Sale$8.0049,035392,280428,232Feb 24, 2015, 04:23 PM
BERGER HARVEY J M DChairman & CEOFeb 12, 2015 Buy$6.9012,50086,2801,864,286Feb 13, 2015, 04:21 PM
BERGER HARVEY J M DChairman & CEOFeb 11, 2015 Buy$6.7712,50084,5691,851,786Feb 13, 2015, 04:21 PM
Haluska FrankSVP, Clinical R&D, CMOFeb 02, 2015 Sale$6.3316,134102,107108,499Feb 04, 2015, 04:52 PM
Cantor Maria ESVP, Corporate Affairs and HRFeb 02, 2015 Sale$6.3316,134102,089100,129Feb 04, 2015, 04:19 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityFeb 02, 2015 Sale$6.3314,66792,823137,722Feb 04, 2015, 04:18 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 02, 2015 Sale$6.3314,66792,820428,232Feb 04, 2015, 04:17 PM
Duvall Martin JEVP, CCOFeb 02, 2015 Sale$6.3314,66792,82350,117Feb 04, 2015, 04:16 PM
FITZGERALD EDWARD MExecutive VP, CFOFeb 02, 2015 Sale$6.3314,66792,849295,627Feb 04, 2015, 04:16 PM
BERSTEIN DAVID LSVP, Chief IP CounselFeb 02, 2015 Sale$6.3314,66792,826222,074Feb 04, 2015, 04:14 PM
BERGER HARVEY J M DChairman & CEOJan 23, 2015 Buy$6.1812,50077,2501,839,286Jan 26, 2015, 04:09 PM
BERGER HARVEY J M DChairman & CEOJan 22, 2015 Buy$6.1612,50076,9901,826,786Jan 26, 2015, 04:09 PM
Schlesinger Sarah J.DirectorJan 13, 2015 Buy$6.971,3009,06114,300Jan 15, 2015, 04:30 PM
Schlesinger Sarah J.DirectorJan 14, 2015 Buy$6.251,3008,12515,600Jan 15, 2015, 04:30 PM
BERGER HARVEY J M DChairman & CEODec 18, 2014 Buy$6.5412,50081,7701,814,286Dec 19, 2014, 04:29 PM
BERGER HARVEY J M DChairman & CEODec 17, 2014 Buy$6.1512,50076,8751,801,786Dec 19, 2014, 04:29 PM
Schlesinger Sarah J.DirectorDec 17, 2014 Buy$6.111,3007,94313,000Dec 18, 2014, 04:09 PM
Schlesinger Sarah J.DirectorDec 16, 2014 Buy$6.071,3007,89111,700Dec 18, 2014, 04:09 PM
Cantor Maria ESVP, Corporate Affairs and HRNov 24, 2014 Sale$7.001,74912,24386,929Nov 25, 2014, 04:22 PM
BERGER HARVEY J M DChairman & CEONov 20, 2014 Buy$6.1512,50076,8891,789,286Nov 21, 2014, 04:18 PM
BERGER HARVEY J M DChairman & CEONov 19, 2014 Buy$6.1512,50076,8531,776,786Nov 21, 2014, 04:18 PM
Schlesinger Sarah J.DirectorNov 12, 2014 Buy$6.221,3008,08610,400Nov 13, 2014, 04:27 PM
Schlesinger Sarah J.DirectorNov 11, 2014 Buy$6.301,3008,1909,100Nov 13, 2014, 04:27 PM
BERGER HARVEY J M DChairman & CEOOct 16, 2014 Buy$5.3912,50067,3171,764,286Oct 17, 2014, 04:24 PM
BERGER HARVEY J M DChairman & CEOOct 15, 2014 Buy$5.1012,50063,7271,751,786Oct 17, 2014, 04:24 PM
Schlesinger Sarah J.DirectorOct 15, 2014 Buy$5.031,3006,5397,800Oct 16, 2014, 04:27 PM
Schlesinger Sarah J.DirectorOct 14, 2014 Buy$5.071,3006,5916,500Oct 16, 2014, 04:27 PM
BERGER HARVEY J M DChairman & CEOSep 03, 2014 Buy$6.3112,50078,8591,739,286Sep 18, 2014, 04:30 PM
BERGER HARVEY J M DChairman & CEOSep 02, 2014 Buy$6.2212,50077,7771,726,786Sep 18, 2014, 04:30 PM
BERSTEIN DAVID LSVP, GC and Chief IP OfficerSep 09, 2014 Option Exercise$5.757,11840,929236,741Sep 11, 2014, 04:41 PM
BERSTEIN DAVID LSVP, GC and Chief IP OfficerSep 09, 2014 Option Exercise$5.237,82540,925147,983Sep 11, 2014, 04:41 PM
BERGER HARVEY J M DChairman & CEOSep 09, 2014 Option Exercise$5.75124,613716,5251,163,564Sep 11, 2014, 04:39 PM
BERGER HARVEY J M DChairman & CEOSep 09, 2014 Option Exercise$5.23150,000784,5001,294,277Sep 11, 2014, 04:39 PM
BERGER HARVEY J M DChairman & CEOSep 03, 2014 Buy$6.3112,50078,8591,739,286Sep 11, 2014, 04:39 PM
BERGER HARVEY J M DChairman & CEOSep 02, 2014 Buy$6.2212,50077,7771,726,786Sep 11, 2014, 04:39 PM
Schlesinger Sarah J.DirectorAug 13, 2014 Buy$5.711,3007,4232,600Sep 11, 2014, 04:38 PM
Schlesinger Sarah J.DirectorAug 12, 2014 Buy$5.521,3007,1761,300Sep 11, 2014, 04:38 PM
Schlesinger Sarah J.DirectorSep 10, 2014 Buy$5.751,3007,4755,200Sep 11, 2014, 04:38 PM
Schlesinger Sarah J.DirectorSep 09, 2014 Buy$5.931,3007,7093,900Sep 11, 2014, 04:38 PM
FITZGERALD EDWARD MExecutive VP, CFOSep 02, 2014 Option Exercise$5.2350,000261,500305,960Sep 04, 2014, 04:24 PM
FITZGERALD EDWARD MExecutive VP, CFOSep 02, 2014 Sale$6.2250,000310,835280,960Sep 04, 2014, 04:24 PM
Cantor Maria ESVP, Corporate Affairs and HRSep 02, 2014 Sale$6.212,69616,75388,678Sep 04, 2014, 04:22 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 02, 2014 Option Exercise$1.3026,25034,125179,705Sep 04, 2014, 04:21 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 02, 2014 Sale$6.2256,650352,227153,455Sep 04, 2014, 04:21 PM
DENNER ALEXANDER JDirectorAug 15, 2014 Buy$5.83615,4663,588,1677,798,665Aug 19, 2014, 06:04 PM
DENNER ALEXANDER JDirectorAug 15, 2014 Buy$5.83234,5341,367,3335,051,335Aug 19, 2014, 06:04 PM
BERSTEIN DAVID LSVP, GC and Chief IP OfficerJul 15, 2014 Option Exercise$5.572,60814,527236,034Jul 17, 2014, 05:04 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJul 15, 2014 Option Exercise$5.572,60814,527153,455Jul 17, 2014, 05:03 PM
Cantor Maria ESVP, Corporate Affairs and HRJul 15, 2014 Option Exercise$5.572,60814,52791,374Jul 17, 2014, 05:02 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 15, 2014 Option Exercise$5.574,56425,421413,565Jul 17, 2014, 05:02 PM
Haluska FrankSVP, Clinical R&D, CMOJul 15, 2014 Option Exercise$5.572,60814,52795,299Jul 17, 2014, 05:01 PM
FITZGERALD EDWARD MExecutive VP, CFOJul 15, 2014 Option Exercise$5.574,56425,421280,960Jul 17, 2014, 05:00 PM
BERGER HARVEY J M DChairman & CEOJul 15, 2014 Option Exercise$5.5715,55686,6471,122,621Jul 17, 2014, 04:59 PM
Duvall Martin JEVP, CCOJul 15, 2014 Option Exercise$5.579135,08535,450Jul 17, 2014, 04:58 PM
Cantor Maria ESVP, Corporate Affairs and HRJun 02, 2014 Sale$6.903,71325,61184,461Jun 04, 2014, 04:29 PM
Haluska FrankSVP, Clinical R&D, CMOApr 02, 2014 Sale$8.213,40027,916104,296Apr 03, 2014, 04:32 PM
BERSTEIN DAVID LSVP, GC and Chief IP OfficerApr 02, 2014 Sale$8.222,40019,718230,642Apr 03, 2014, 04:31 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityApr 02, 2014 Sale$8.222,40019,720148,063Apr 03, 2014, 04:30 PM
FITZGERALD EDWARD MExecutive VP, CFOApr 01, 2014 Option Exercise$8.524,23836,108270,928Apr 03, 2014, 04:29 PM
BERGER HARVEY J M DChairman & CEOApr 01, 2014 Option Exercise$8.5213,584115,7361,129,324Apr 03, 2014, 04:28 PM
Cantor Maria ESVP, Corporate Affairs and HRApr 02, 2014 Sale$8.214,25034,90788,174Apr 03, 2014, 04:28 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 02, 2014 Sale$8.216,50053,337403,028Apr 03, 2014, 04:27 PM
Cantor Maria ESVP, Corporate Affairs and HRMar 19, 2014 Option Exercise$8.192,06116,88078,713Mar 21, 2014, 05:30 PM
Cantor Maria ESVP, Corporate Affairs and HRMar 21, 2014 Sale$7.893,66728,93082,379Mar 21, 2014, 05:30 PM
BERSTEIN DAVID LSVP, GC and Chief IP OfficerMar 19, 2014 Option Exercise$8.191,50612,334224,642Mar 21, 2014, 05:28 PM
BERSTEIN DAVID LSVP, GC and Chief IP OfficerMar 21, 2014 Sale$7.891,60012,630227,042Mar 21, 2014, 05:28 PM
Haluska FrankSVP, Clinical R&D, CMOMar 19, 2014 Option Exercise$8.192,06116,88095,596Mar 21, 2014, 05:28 PM
Haluska FrankSVP, Clinical R&D, CMOMar 21, 2014 Sale$7.892,40018,94199,196Mar 21, 2014, 05:28 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 19, 2014 Option Exercise$8.192,53620,770140,863Mar 21, 2014, 05:21 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 21, 2014 Sale$7.892,40018,936144,463Mar 21, 2014, 05:21 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 19, 2014 Option Exercise$8.193,44228,190387,711Mar 21, 2014, 05:20 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 21, 2014 Sale$7.896,66752,583394,377Mar 21, 2014, 05:20 PM
Duvall Martin JEVP, CCOMar 20, 2014 Option Exercise$8.135294,30130,340Mar 21, 2014, 04:11 PM
Duvall Martin JEVP, CCOMar 19, 2014 Option Exercise$8.192,61821,44129,203Mar 21, 2014, 04:11 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 19, 2014 Option Exercise$8.193,43528,133255,940Mar 21, 2014, 04:10 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 20, 2014 Option Exercise$8.132,71722,089261,556Mar 21, 2014, 04:10 PM
BERGER HARVEY J M DChairman & CEOMar 20, 2014 Option Exercise$8.1311,08490,1131,097,964Mar 21, 2014, 04:09 PM
BERGER HARVEY J M DChairman & CEOMar 19, 2014 Option Exercise$8.1911,71195,9131,075,048Mar 21, 2014, 04:09 PM
CLACKSON TIMOTHY PPresident, R&D, CSODec 19, 2013 Sale$5.149,75050,115380,319Dec 20, 2013, 04:39 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityDec 19, 2013 Sale$5.153,60018,528135,399Dec 20, 2013, 04:38 PM
Cantor Maria ESVP, Corporate AffairsDec 19, 2013 Sale$5.146,37532,76774,274Dec 20, 2013, 04:35 PM
BERGER HARVEY J M DChairman & CEODec 18, 2013 Option Exercise$4.9829,500146,9101,050,759Dec 20, 2013, 04:33 PM
Haluska FrankSVP, Clinical R&D, CMODec 19, 2013 Sale$5.145,10026,21491,157Dec 20, 2013, 04:33 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerDec 19, 2013 Sale$5.144,50023,130221,398Dec 20, 2013, 04:31 PM
Duvall Martin JSVP, Commercial OperationsSep 19, 2013 Option Exercise$21.4910,918234,62823,821Sep 24, 2013, 04:03 PM
CLACKSON TIMOTHY PPresident, R&D, CSOSep 06, 2013 Sale$22.008,449185,878370,451Sep 10, 2013, 04:32 PM
FITZGERALD EDWARD MExecutive VP, CFOAug 15, 2013 Option Exercise$18.1119,342350,284228,243Aug 16, 2013, 04:23 PM
FITZGERALD EDWARD MExecutive VP, CFOAug 15, 2013 Option Exercise$3.9033,000128,700247,585Aug 16, 2013, 04:23 PM
BERGER HARVEY J M DChairman & CEOAug 13, 2013 Sale$18.1150,000905,5551,305,661Aug 15, 2013, 04:26 PM
BERGER HARVEY J M DChairman & CEOAug 14, 2013 Sale$18.373,15757,9990Aug 15, 2013, 04:26 PM
BERGER HARVEY J M DChairman & CEOAug 14, 2013 Sale$18.5162,9021,164,3351,242,759Aug 15, 2013, 04:26 PM
BERGER HARVEY J M DChairman & CEOAug 13, 2013 Sale$18.362,70049,5703,157Aug 15, 2013, 04:26 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJul 18, 2013 Sale$19.796,400126,639129,978Jul 18, 2013, 05:53 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerJul 18, 2013 Sale$19.798,000158,290216,898Jul 18, 2013, 05:53 PM
Haluska FrankSVP, Clinical R&D, CMOJul 18, 2013 Sale$19.796,400126,64283,507Jul 18, 2013, 05:51 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsJul 18, 2013 Sale$19.796,400126,65567,282Jul 18, 2013, 05:50 PM
Keane Raymond TSVP General Counsel & CCOJul 18, 2013 Sale$19.798,000158,28662,096Jul 18, 2013, 05:49 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 18, 2013 Sale$19.7914,000277,045378,900Jul 18, 2013, 05:47 PM
Cantor Maria ESVP, Corporate AffairsJul 18, 2013 Sale$19.798,000158,29967,724Jul 18, 2013, 05:46 PM
BERGER HARVEY J M DChairman & CEOJul 17, 2013 Sale$19.602,70052,9125,857Jul 18, 2013, 04:21 PM
BERGER HARVEY J M DChairman & CEOJul 17, 2013 Sale$19.6150,000980,7051,355,861Jul 18, 2013, 04:21 PM
BERGER HARVEY J M DChairman & CEOJul 16, 2013 Sale$20.972,70056,6238,557Jul 18, 2013, 04:21 PM
BERGER HARVEY J M DChairman & CEOJul 16, 2013 Sale$19.91144,0002,866,4781,405,861Jul 18, 2013, 04:21 PM
BERGER HARVEY J M DChairman & CEOJul 15, 2013 Option Exercise$20.9834,776729,6001,549,861Jul 17, 2013, 04:42 PM
FITZGERALD EDWARD MExecutive VP, CFOJul 15, 2013 Option Exercise$20.9813,230277,565214,585Jul 17, 2013, 04:38 PM
BERGER HARVEY J M DChairman & CEOJun 19, 2013 Sale$18.005,800104,4151,511,037Jun 21, 2013, 04:19 PM
BERGER HARVEY J M DChairman & CEOJun 19, 2013 Sale$18.005,40097,20811,257Jun 21, 2013, 04:19 PM
BERGER HARVEY J M DChairman & CEOMay 15, 2013 Sale$18.142,70048,98316,657May 16, 2013, 04:38 PM
BERGER HARVEY J M DChairman & CEOMay 15, 2013 Sale$18.2237,098675,9701,516,837May 16, 2013, 04:38 PM
BERGER HARVEY J M DChairman & CEOMay 14, 2013 Sale$18.002,70048,60019,357May 16, 2013, 04:38 PM
BERGER HARVEY J M DChairman & CEOMay 14, 2013 Sale$18.0150,000900,2951,553,935May 16, 2013, 04:38 PM
BERGER HARVEY J M DChairman & CEOApr 17, 2013 Sale$18.005,40097,20122,057Apr 22, 2013, 05:07 PM
BERGER HARVEY J M DChairman & CEOApr 17, 2013 Sale$18.01100,0001,800,5901,667,521Apr 22, 2013, 05:07 PM
Keane Raymond TSVP General Counsel & CCOApr 02, 2013 Sale$18.052,58346,62554,096Apr 03, 2013, 04:58 PM
Haluska FrankSVP, Clinical R&D, CMOApr 02, 2013 Sale$18.043,40061,33973,907Apr 03, 2013, 04:57 PM
Cantor Maria ESVP, Corporate AffairsApr 02, 2013 Sale$18.044,25076,66562,275Apr 03, 2013, 04:55 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 02, 2013 Sale$18.046,500117,245363,705Apr 03, 2013, 04:53 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsApr 02, 2013 Sale$18.042,40043,29557,682Apr 03, 2013, 04:52 PM
BERGER HARVEY J M DChairman & CEOApr 01, 2013 Option Exercise$18.3019,688360,2901,767,521Apr 03, 2013, 04:51 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerApr 02, 2013 Sale$18.052,40043,322208,898Apr 03, 2013, 04:47 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 26, 2013 Sale$18.7512,933242,492191,555Mar 26, 2013, 04:57 PM
Keane Raymond TSVP General Counsel & CCOMar 25, 2013 Sale$18.8713,167248,48251,513Mar 26, 2013, 04:40 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsMar 25, 2013 Sale$18.878,133153,48254,082Mar 26, 2013, 04:38 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 25, 2013 Sale$18.8710,533198,807205,298Mar 26, 2013, 04:36 PM
Haluska FrankSVP, Clinical R&D, CMOMar 25, 2013 Sale$18.885,333100,67268,807Mar 26, 2013, 04:36 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 25, 2013 Sale$18.8719,167361,766357,205Mar 26, 2013, 04:34 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 25, 2013 Sale$18.8712,933244,079114,271Mar 26, 2013, 04:32 PM
Cantor Maria ESVP, Corporate AffairsMar 22, 2013 Option Exercise$19.385,877113,89658,025Mar 26, 2013, 04:32 PM
BERGER HARVEY J M DChairman & CEOMar 22, 2013 Option Exercise$19.3846,148894,3481,745,543Mar 26, 2013, 04:30 PM
BERGER HARVEY J M DChairman & CEOMar 20, 2013 Option Exercise$20.4516,065328,5291,694,024Mar 22, 2013, 07:07 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 20, 2013 Option Exercise$20.452,72255,665172,155Mar 22, 2013, 07:02 PM
Duvall Martin JSVP, Commercial OperationsMar 22, 2013 Sale$19.5357611,2492,854Mar 22, 2013, 06:51 PM
Keane Raymond TSVP General Counsel & CCOMar 22, 2013 Sale$19.462,33445,42338,347Mar 22, 2013, 06:38 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsMar 22, 2013 Sale$19.462,40046,69841,882Mar 22, 2013, 06:31 PM
Haluska FrankSVP, Clinical R&D, CMOMar 22, 2013 Sale$19.462,40046,69460,807Mar 22, 2013, 06:29 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 22, 2013 Sale$19.462,40046,69494,871Mar 22, 2013, 06:09 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 22, 2013 Sale$19.461,60031,135189,498Mar 22, 2013, 06:05 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 22, 2013 Sale$19.466,667129,718338,039Mar 22, 2013, 06:03 PM
Cantor Maria ESVP, Corporate AffairsMar 22, 2013 Sale$19.453,66771,33542,235Mar 22, 2013, 05:14 PM
BERGER HARVEY J M DChairman & CEOMar 13, 2013 Sale$22.0650,0001,102,9901,676,089Mar 14, 2013, 04:33 PM
BERGER HARVEY J M DChairman & CEOMar 13, 2013 Sale$22.072,70059,58727,457Mar 14, 2013, 04:33 PM
BERGER HARVEY J M DChairman & CEOMar 12, 2013 Sale$22.0450,0001,101,7551,726,089Mar 14, 2013, 04:33 PM
BERGER HARVEY J M DChairman & CEOMar 12, 2013 Sale$22.042,70059,51630,157Mar 14, 2013, 04:33 PM
Cantor Maria ESVP, Corporate AffairsMar 12, 2013 Sale$22.002,10546,31038,568Mar 13, 2013, 04:35 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 04, 2013 Sale$21.009,838206,598331,372Mar 05, 2013, 04:44 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJan 15, 2013 Option Exercise$5.0557,939292,414341,210Jan 17, 2013, 04:44 PM
FITZGERALD EDWARD MExecutive VP, CFOJan 02, 2013 Sale$20.0825,000501,890166,543Jan 03, 2013, 04:30 PM
LAVIDAS ATHANESEDirectorDec 21, 2012 Sale$20.3110,500213,20980,131Dec 27, 2012, 04:45 PM
CLACKSON TIMOTHY PPresident, R&D, CSODec 20, 2012 Option Exercise$5.2327,000141,210282,940Dec 21, 2012, 04:28 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityDec 18, 2012 Option Exercise$20.183,75875,83691,271Dec 20, 2012, 04:46 PM
Cantor Maria ESVP, Corporate AffairsDec 18, 2012 Option Exercise$20.185,324107,43840,673Dec 20, 2012, 04:44 PM
CLACKSON TIMOTHY PPresident, R&D, CSODec 18, 2012 Option Exercise$20.188,142164,306255,940Dec 20, 2012, 04:41 PM
FITZGERALD EDWARD MExecutive VP, CFODec 18, 2012 Option Exercise$20.188,142164,306191,357Dec 20, 2012, 04:39 PM
Haluska FrankSVP, Clinical R&D, CMODec 18, 2012 Option Exercise$20.185,324107,43857,207Dec 20, 2012, 04:37 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsDec 18, 2012 Option Exercise$20.183,75875,83638,282Dec 20, 2012, 04:35 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerDec 18, 2012 Option Exercise$20.183,75875,836187,098Dec 20, 2012, 04:30 PM
BERGER HARVEY J M DChairman & CEODec 18, 2012 Option Exercise$20.1826,094526,5772,226,089Dec 20, 2012, 04:27 PM
Keane Raymond TSVP General Counsel & CCODec 18, 2012 Option Exercise$20.183,23665,30236,014Dec 20, 2012, 04:24 PM
LAMARCHE JAY RDirectorOct 01, 2012 Sale$24.9910,000249,932400,705Oct 03, 2012, 04:02 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityOct 01, 2012 Option Exercise$1.307,5009,75093,019Oct 02, 2012, 04:13 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityOct 01, 2012 Sale$25.007,500187,50085,519Oct 02, 2012, 04:13 PM
FITZGERALD EDWARD MExecutive VP, CFOOct 01, 2012 Sale$24.1725,000604,187179,767Oct 02, 2012, 04:11 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 19, 2012 Option Exercise$1.307,5009,75093,019Sep 20, 2012, 12:34 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 19, 2012 Sale$24.007,500180,00085,519Sep 20, 2012, 12:34 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 19, 2012 Option Exercise$5.2311,37559,491201,231Sep 20, 2012, 12:32 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 19, 2012 Sale$24.0019,375465,000189,856Sep 20, 2012, 12:32 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 11, 2012 Option Exercise$1.307,5009,75093,019Sep 12, 2012, 04:10 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualitySep 11, 2012 Sale$23.007,500172,50085,519Sep 12, 2012, 04:10 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 11, 2012 Option Exercise$5.2311,37559,491201,231Sep 12, 2012, 04:05 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 11, 2012 Sale$23.0019,375445,625189,856Sep 12, 2012, 04:05 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 11, 2012 Option Exercise$5.2311,37559,491201,231Sep 12, 2012, 04:02 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 11, 2012 Sale$23.0019,375445,625189,856Sep 12, 2012, 04:02 PM
LAMARCHE JAY RDirectorSep 06, 2012 Option Exercise$2.6615,00039,900533,893Sep 11, 2012, 04:15 PM
LAMARCHE JAY RDirectorSep 06, 2012 Option Exercise$2.6615,00039,900525,205Sep 07, 2012, 04:55 PM
Keane Raymond TSVP General Counsel & CCOSep 06, 2012 Option Exercise$2.3910,00023,90041,500Sep 07, 2012, 04:18 PM
Keane Raymond TSVP General Counsel & CCOSep 06, 2012 Sale$22.0010,000220,00031,500Sep 07, 2012, 04:18 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 06, 2012 Option Exercise$5.2311,37559,491205,700Sep 07, 2012, 04:16 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 06, 2012 Sale$22.0019,375426,250197,856Sep 07, 2012, 04:16 PM
Keane Raymond TSVP General Counsel & CCOSep 04, 2012 Sale$21.007,780163,38031,500Sep 05, 2012, 04:18 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 04, 2012 Option Exercise$5.238,05042,102221,906Sep 05, 2012, 04:15 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerSep 04, 2012 Sale$21.0016,050337,050213,856Sep 05, 2012, 04:15 PM
CLACKSON TIMOTHY PPresident, R&D, CSOAug 30, 2012 Option Exercise$3.2510,00132,503244,170Sep 04, 2012, 04:08 PM
LAMARCHE JAY RDirectorAug 15, 2012 Sale$20.0020,000400,032518,893Aug 16, 2012, 04:10 PM
Keane Raymond TSVP General Counsel & CCOAug 15, 2012 Option Exercise$2.3910,00023,90049,280Aug 16, 2012, 04:09 PM
Keane Raymond TSVP General Counsel & CCOAug 15, 2012 Sale$20.0010,000200,00039,280Aug 16, 2012, 04:09 PM
CLACKSON TIMOTHY PPresident, R&D, CSOAug 15, 2012 Option Exercise$7.5636,843278,533271,012Aug 16, 2012, 04:07 PM
CLACKSON TIMOTHY PPresident, R&D, CSOAug 15, 2012 Sale$20.0036,843736,860234,169Aug 16, 2012, 04:07 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerAug 15, 2012 Sale$20.008,000160,000213,856Aug 16, 2012, 04:05 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsJul 30, 2012 Option Exercise$5.4925,000137,25061,640Aug 01, 2012, 04:45 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsJul 30, 2012 Sale$19.0028,600543,40033,040Aug 01, 2012, 04:45 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerJul 30, 2012 Sale$19.008,000152,000221,856Aug 01, 2012, 04:12 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 30, 2012 Option Exercise$5.2323,234121,514257,403Aug 01, 2012, 04:07 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJul 30, 2012 Sale$19.0023,234441,446234,169Aug 01, 2012, 04:07 PM
Keane Raymond TSVP General Counsel & CCOJul 30, 2012 Sale$19.0010,000190,00039,280Aug 01, 2012, 04:06 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJul 30, 2012 Option Exercise$1.307,5009,75093,091Aug 01, 2012, 04:05 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJul 30, 2012 Sale$19.007,500142,50085,519Aug 01, 2012, 04:05 PM
Cantor Maria ESVP, Corporate AffairsJul 30, 2012 Option Exercise$7.826,47850,65839,326Aug 01, 2012, 04:04 PM
Cantor Maria ESVP, Corporate AffairsJul 30, 2012 Sale$19.006,478123,08232,848Aug 01, 2012, 04:04 PM
Keane Raymond TSVP General Counsel & CCOJul 26, 2012 Option Exercise$2.3910,00023,90059,280Jul 27, 2012, 03:03 PM
Keane Raymond TSVP General Counsel & CCOJul 26, 2012 Sale$18.0010,000180,00049,280Jul 27, 2012, 03:03 PM
LAVIDAS ATHANESEDirectorJul 20, 2012 Sale$18.005,00089,97790,631Jul 23, 2012, 04:33 PM
FITZGERALD EDWARD MExecutive VP, CFOJul 02, 2012 Sale$17.6425,000440,950204,767Jul 05, 2012, 04:23 PM
Cantor Maria ESVP, Corporate AffairsJun 25, 2012 Sale$17.111,76530,19932,337Jun 26, 2012, 04:29 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJun 22, 2012 Option Exercise$1.307,5009,75092,595Jun 25, 2012, 04:30 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityJun 22, 2012 Sale$17.507,500131,26985,095Jun 25, 2012, 04:30 PM
LAVIDAS ATHANESEDirectorJun 20, 2012 Sale$17.415,00087,02895,631Jun 22, 2012, 04:30 PM
Cantor Maria ESVP, Corporate AffairsJun 19, 2012 Option Exercise$3.087,50023,10041,602Jun 21, 2012, 04:03 PM
Cantor Maria ESVP, Corporate AffairsJun 19, 2012 Sale$18.007,500135,00034,102Jun 21, 2012, 04:03 PM
BERGER HARVEY J M DChairman & CEOJun 13, 2012 Option Exercise$16.795,95599,9842,189,683Jun 15, 2012, 04:27 PM
BERGER HARVEY J M DChairman & CEOJun 13, 2012 Option Exercise$4.0524,69199,9992,195,638Jun 15, 2012, 04:27 PM
LAVIDAS ATHANESEDirectorJun 05, 2012 Option Exercise$6.3925,000159,750125,631Jun 07, 2012, 04:21 PM
LAVIDAS ATHANESEDirectorJun 05, 2012 Sale$16.0525,000401,280100,631Jun 07, 2012, 04:21 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMay 21, 2012 Option Exercise$4.1926,075109,254263,931May 23, 2012, 04:05 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 26, 2012 Sale$16.008,000128,000229,856May 23, 2012, 04:05 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMay 21, 2012 Sale$16.5426,075431,398237,856May 23, 2012, 04:05 PM
LAVIDAS ATHANESEDirectorMay 21, 2012 Sale$16.545,00082,690100,631May 23, 2012, 04:04 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsMay 16, 2012 Sale$17.5022,130387,27536,640May 17, 2012, 04:30 PM
FITZGERALD EDWARD MExecutive VP, CFOMay 03, 2012 Option Exercise$4.6360,000277,800229,548May 04, 2012, 04:33 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMay 02, 2012 Option Exercise$7.4420,000148,800253,778May 04, 2012, 04:31 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMay 02, 2012 Sale$17.0020,000340,000233,778May 04, 2012, 04:31 PM
Haluska FrankSVP, Clinical R&D, CMOMay 02, 2012 Option Exercise$2.393,0007,17052,781May 04, 2012, 04:29 PM
Haluska FrankSVP, Clinical R&D, CMOMay 02, 2012 Sale$17.003,00051,00049,781May 04, 2012, 04:29 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMay 02, 2012 Option Exercise$4.1911,37547,661257,231May 04, 2012, 04:27 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMay 02, 2012 Sale$17.0019,375329,375245,856May 04, 2012, 04:27 PM
LAVIDAS ATHANESEDirectorApr 20, 2012 Sale$15.0610,000150,558105,631Apr 24, 2012, 04:30 PM
FITZGERALD EDWARD MExecutive VP, CFOApr 17, 2012 Option Exercise$4.6340,000185,200209,548Apr 18, 2012, 04:33 PM
FITZGERALD EDWARD MExecutive VP, CFOApr 17, 2012 Sale$15.0040,000600,000169,548Apr 18, 2012, 04:33 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 17, 2012 Sale$15.007,111106,665233,778Apr 17, 2012, 04:28 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 13, 2012 Sale$14.8331,600468,628240,889Apr 17, 2012, 04:28 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsApr 12, 2012 Sale$15.3917,062262,57658,770Apr 16, 2012, 04:27 PM
LAVIDAS ATHANESEDirectorApr 09, 2012 Sale$15.7615,000236,350115,631Apr 11, 2012, 04:31 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsApr 02, 2012 Option Exercise$7.8210,66783,41686,499Apr 04, 2012, 04:02 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsApr 02, 2012 Sale$16.1110,667171,88775,832Apr 04, 2012, 04:02 PM
Cantor Maria ESVP, Corporate AffairsApr 03, 2012 Sale$16.183,40055,02733,327Apr 03, 2012, 06:02 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 03, 2012 Sale$16.185,20084,134272,489Apr 03, 2012, 05:58 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 26, 2012 Sale$16.3426,061425,876264,689Apr 03, 2012, 05:58 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerApr 03, 2012 Sale$16.192,40038,844245,856Apr 03, 2012, 05:57 PM
Keane Raymond TSVP General Counsel & CCOApr 03, 2012 Sale$16.192,06733,45548,980Apr 03, 2012, 05:56 PM
FITZGERALD EDWARD MExecutive VP, CFOApr 03, 2012 Sale$16.185,20084,156167,880Apr 03, 2012, 05:56 PM
BERGER HARVEY J M DChairman & CEOApr 02, 2012 Option Exercise$16.2317,396282,3372,170,947Apr 03, 2012, 05:54 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityApr 02, 2012 Option Exercise$16.231,90530,91885,095Apr 03, 2012, 05:54 PM
Haluska FrankSVP, Clinical R&D, CMOApr 03, 2012 Sale$16.184,25068,76749,781Apr 03, 2012, 05:53 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsApr 03, 2012 Sale$16.182,40038,83675,832Apr 03, 2012, 05:52 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 26, 2012 Option Exercise$6.397,50047,925298,250Mar 28, 2012, 04:18 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 26, 2012 Sale$16.007,500120,000290,750Mar 28, 2012, 04:18 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 26, 2012 Option Exercise$4.1911,37547,661253,631Mar 28, 2012, 04:17 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 26, 2012 Sale$16.0011,375182,000242,256Mar 28, 2012, 04:17 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsMar 26, 2012 Option Exercise$5.4925,000137,25097,232Mar 28, 2012, 04:16 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsMar 26, 2012 Sale$16.5025,000412,50072,232Mar 28, 2012, 04:16 PM
Cantor Maria ESVP, Corporate AffairsMar 26, 2012 Option Exercise$3.086,00018,48052,227Mar 28, 2012, 04:15 PM
Cantor Maria ESVP, Corporate AffairsMar 27, 2012 Sale$16.2318,000292,13828,227Mar 28, 2012, 04:15 PM
Cantor Maria ESVP, Corporate AffairsMar 26, 2012 Sale$16.006,00096,00046,227Mar 28, 2012, 04:15 PM
Haluska FrankSVP, Clinical R&D, CMOMar 26, 2012 Option Exercise$2.393,0007,17048,531Mar 28, 2012, 04:15 PM
Haluska FrankSVP, Clinical R&D, CMOMar 26, 2012 Sale$16.003,00048,00045,531Mar 28, 2012, 04:15 PM
Haluska FrankSVP, Clinical R&D, CMOMar 23, 2012 Sale$15.416,667102,71845,531Mar 26, 2012, 04:45 PM
Keane Raymond TSVP General Counsel & CCOMar 23, 2012 Sale$15.4110,533162,27145,880Mar 26, 2012, 04:44 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsMar 23, 2012 Sale$15.2924,901380,71289,000Mar 26, 2012, 04:43 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 23, 2012 Sale$15.4112,933199,239160,080Mar 26, 2012, 04:41 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 22, 2012 Option Exercise$15.6810,343162,17881,000Mar 26, 2012, 04:39 PM
BERGER HARVEY J M DChairman & CEOMar 22, 2012 Option Exercise$15.6840,776639,3682,146,676Mar 26, 2012, 04:38 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 23, 2012 Sale$15.4115,333236,211290,750Mar 26, 2012, 04:37 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 23, 2012 Sale$15.4110,533162,274242,256Mar 26, 2012, 04:36 PM
BERGER HARVEY J M DChairman & CEOMar 20, 2012 Option Exercise$15.0510,438157,0922,089,786Mar 22, 2012, 04:34 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 20, 2012 Sale$15.0218,800282,314226,456Mar 21, 2012, 06:08 PM
Keane Raymond TSVP General Counsel & CCOMar 20, 2012 Sale$15.028,400126,15530,380Mar 21, 2012, 06:06 PM
Haluska FrankSVP, Clinical R&D, CMOMar 20, 2012 Sale$15.0215,000225,24038,865Mar 21, 2012, 06:05 PM
FITZGERALD EDWARD MExecutive VP, CFOMar 20, 2012 Sale$15.0231,200468,605140,680Mar 21, 2012, 06:04 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsMar 20, 2012 Sale$15.0112,980194,79976,800Mar 21, 2012, 06:03 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 20, 2012 Sale$15.0236,400546,622267,750Mar 21, 2012, 06:02 PM
Cantor Maria ESVP, Corporate AffairsMar 20, 2012 Sale$15.0214,000210,21828,277Mar 21, 2012, 06:02 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 16, 2012 Option Exercise$4.1315,06462,192213,150Mar 19, 2012, 04:30 PM
BERGER HARVEY J M DChairman & CEOMar 10, 2012 Option Exercise$14.9566,800998,6602,008,424Mar 13, 2012, 05:05 PM
LAMARCHE JAY RDirectorFeb 28, 2012 Option Exercise$4.4420,00088,800538,893Mar 01, 2012, 04:29 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerFeb 28, 2012 Option Exercise$3.9311,37544,703209,631Mar 01, 2012, 04:28 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerFeb 28, 2012 Sale$15.5011,375176,313198,256Mar 01, 2012, 04:28 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsFeb 23, 2012 Option Exercise$5.4925,000137,25055,780Feb 24, 2012, 04:31 PM
DODION PIERRE FSVP, Corp. Dev. & OperationsFeb 23, 2012 Sale$15.0025,000375,00030,780Feb 24, 2012, 04:31 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerFeb 23, 2012 Sale$15.004,10061,500198,256Feb 24, 2012, 04:30 PM
Haluska FrankSVP, Clinical R&D, CMOFeb 21, 2012 Option Exercise$2.394,50010,75528,365Feb 23, 2012, 04:32 PM
Haluska FrankSVP, Clinical R&D, CMOFeb 21, 2012 Sale$14.514,50065,27723,865Feb 23, 2012, 04:32 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerFeb 21, 2012 Option Exercise$3.9022,80088,920237,456Feb 23, 2012, 04:31 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerFeb 21, 2012 Sale$14.5035,100509,032214,656Feb 23, 2012, 04:31 PM
BERGER HARVEY J M DChairman & CEOFeb 15, 2012 Option Exercise$15.0522,912344,8261,915,224Feb 17, 2012, 04:30 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 14, 2012 Option Exercise$3.9016,50064,350138,150Feb 17, 2012, 04:29 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 14, 2012 Sale$15.5016,500255,750121,650Feb 17, 2012, 04:29 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 14, 2012 Option Exercise$4.0976,436312,908196,318Feb 16, 2012, 04:29 PM
CLACKSON TIMOTHY PPresident, R&D, CSOFeb 14, 2012 Sale$15.1276,4361,155,781119,882Feb 16, 2012, 04:29 PM
Keane Raymond TSVP General Counsel & CCOFeb 14, 2012 Option Exercise$1.3012,50016,25030,280Feb 16, 2012, 04:28 PM
Keane Raymond TSVP General Counsel & CCOFeb 14, 2012 Sale$15.1312,500189,17817,780Feb 16, 2012, 04:28 PM
LAMARCHE JAY RDirectorJan 27, 2012 Sale$15.0526,900404,974500,534Jan 31, 2012, 04:32 PM
LAMARCHE JAY RDirectorJan 26, 2012 Sale$15.043,10046,627527,434Jan 27, 2012, 04:24 PM
BERGER HARVEY J M DChairman & CEOJul 26, 2011 Option Exercise$4.8020,837100,0181,938,136Jul 26, 2011, 04:30 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJun 07, 2011 Option Exercise$8.6543,766378,576196,318Jun 09, 2011, 04:22 PM
CLACKSON TIMOTHY PPresident, R&D, CSOJun 07, 2011 Option Exercise$5.6560,000339,000240,084Jun 09, 2011, 04:22 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerJun 07, 2011 Option Exercise$8.6544,145381,854214,656Jun 09, 2011, 04:21 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerJun 07, 2011 Option Exercise$5.6560,000339,000258,801Jun 09, 2011, 04:21 PM
LAMARCHE JAY RDirectorMay 09, 2011 Option Exercise$9.1915,369141,241530,534May 11, 2011, 04:32 PM
LAMARCHE JAY RDirectorMay 09, 2011 Option Exercise$5.6525,000141,250545,903May 11, 2011, 04:32 PM
DODION PIERRE FSenior VP, Corp. DevelopmentApr 11, 2011 Option Exercise$7.767,93861,59930,780Apr 13, 2011, 06:33 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityApr 11, 2011 Option Exercise$7.7615,875123,19059,010Apr 13, 2011, 06:31 PM
CLACKSON TIMOTHY PPresident, R&D, CSOApr 11, 2011 Option Exercise$7.7613,289103,123180,084Apr 13, 2011, 06:30 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerApr 11, 2011 Option Exercise$7.766,98554,204198,801Apr 13, 2011, 06:29 PM
FITZGERALD EDWARD MExecutive VP, CFOApr 11, 2011 Option Exercise$7.7610,06778,12093,880Apr 13, 2011, 06:27 PM
LAMARCHE JAY RDirectorMar 25, 2011 Sale$7.0125,000175,277520,903Mar 29, 2011, 04:29 PM
Keane Raymond TSVP General Counsel & CCOMar 22, 2011 Option Exercise$6.398,55454,66017,780Mar 24, 2011, 05:41 PM
Haluska FrankVP, Clinical R&D, CMOMar 22, 2011 Option Exercise$6.394,40028,11623,865Mar 24, 2011, 05:38 PM
DODION PIERRE FSenior VP, Corp. DevelopmentMar 22, 2011 Option Exercise$6.396,61642,27613,718Mar 24, 2011, 05:35 PM
CLACKSON TIMOTHY PPresident, R&D, CSOMar 22, 2011 Option Exercise$6.3912,27378,424141,373Mar 24, 2011, 05:31 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityMar 22, 2011 Option Exercise$6.3910,44966,76924,885Mar 24, 2011, 05:30 PM
BERSTEIN DAVID LSenior VP, Chief IP OfficerMar 22, 2011 Option Exercise$6.398,50954,373181,910Mar 24, 2011, 05:29 PM
LAMARCHE JAY RDirectorFeb 02, 2011 Sale$6.4825,000161,925545,903Feb 04, 2011, 04:16 PM
LAMARCHE JAY RDirectorJan 11, 2011 Sale$5.5125,000137,675560,003Jan 14, 2011, 04:23 PM
LAMARCHE JAY RDirectorJan 11, 2011 Sale$5.5025,000137,388560,003Jan 13, 2011, 04:30 PM
LAMARCHE JAY RDirectorDec 20, 2010 Sale$5.0025,000125,006576,903Dec 22, 2010, 04:30 PM
Bollag Daniel MSr. VP, Reg. Affairs & QualityOct 26, 2010 Buy$3.703,00011,1003,000Oct 27, 2010, 04:30 PM
CLACKSON TIMOTHY PPres., R & D., Chief Sci. Off.Oct 26, 2010 Buy$3.7010,00037,000117,437Oct 27, 2010, 04:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Cole Hugh MSVP, Chief Business Officer06/25/201554,304
Bollag Daniel MSr. VP, Reg. Affairs & Quality01/31/2017349,293
CLACKSON TIMOTHY PPresident, R&D, CSO01/31/2017228,886
Panayiotopoulos ParisPresident and CEO01/17/2017788,934
Bollag Daniel MSr. VP, Reg. Affairs & Quality01/09/2017250,240
Bollag Daniel MSr. VP, Reg. Affairs & Quality01/09/2017760,960
CLACKSON TIMOTHY PPresident, R&D, CSO10/24/2016187,739
Bollag Daniel MSr. VP, Reg. Affairs & Quality10/03/2016637,812
CLACKSON TIMOTHY PPresident, R&D, CSO09/28/2016122,311
CLACKSON TIMOTHY PPresident, R&D, CSO09/22/2016268,536
CLACKSON TIMOTHY PPresident, R&D, CSO09/15/2016464,266
CLACKSON TIMOTHY PPresident, R&D, CSO09/15/2016696,398
CLACKSON TIMOTHY PPresident, R&D, CSO08/22/2016203,538
CLACKSON TIMOTHY PPresident, R&D, CSO08/12/2016192,250
CLACKSON TIMOTHY PPresident, R&D, CSO08/12/2016262,500
CLACKSON TIMOTHY PPresident, R&D, CSO07/22/2016148,230
Panayiotopoulos ParisPresident and CEO07/13/2016204,283
CLACKSON TIMOTHY PPresident, R&D, CSO07/01/2016238,585
CLACKSON TIMOTHY PPresident, R&D, CSO07/01/2016459,634
Cole Hugh MSVP, Chief Business Officer06/28/201642,385
CLACKSON TIMOTHY PPresident, R&D, CSO06/22/2016174,638
LAVIDAS ATHANESEDirector06/15/2016302,787
LAVIDAS ATHANESEDirector06/14/2016128,800
LAVIDAS ATHANESEDirector06/13/201654,900
LAVIDAS ATHANESEDirector06/15/2016381,137
LAVIDAS ATHANESEDirector06/14/2016162,852
LAVIDAS ATHANESEDirector06/13/201682,050
Radaelli MassimoDirector06/14/201630,687
Radaelli MassimoDirector06/13/2016523,551
Radaelli MassimoDirector06/10/201630,494
Radaelli MassimoDirector06/13/2016657,821
Radaelli MassimoDirector06/10/2016187,480
Radaelli MassimoDirector06/14/201650,834
CLACKSON TIMOTHY PPresident, R&D, CSO05/23/2016143,430
Panayiotopoulos ParisPresident and CEO05/12/2016199,996
Haluska FrankSVP, Clinical R&D, CMO04/29/201640,452
Cantor Maria ESVP, Corporate Affairs04/29/201631,118
Bollag Daniel MSr. VP, Reg. Affairs & Quality04/29/201640,452
Cole Hugh MSVP, Chief Business Officer04/29/201640,452
CLACKSON TIMOTHY PPresident, R&D, CSO05/02/201683,478
Duvall Martin JEVP, CCO04/29/201642,003
CLACKSON TIMOTHY PPresident, R&D, CSO04/22/2016157,864
DesRosier ThomasEVP, General Counsel02/18/201692,401
CLACKSON TIMOTHY PPresident, R&D, CSO03/22/2016156,871
Duvall Martin JEVP, CCO03/19/201625,867
BERSTEIN DAVID LSVP, Chief IP Counsel03/21/201615,356
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/21/201625,871
Cantor Maria ESVP, Corporate Affairs03/19/201623,102
CLACKSON TIMOTHY PPresident, R&D, CSO03/19/201635,039
FITZGERALD EDWARD MExecutive VP03/21/201635,037
Haluska FrankSVP, Clinical R&D, CMO03/21/201623,116
Cole Hugh MSVP, Chief Business Officer03/16/201615,140
Cole Hugh MSVP, Chief Business Officer03/16/201646,575
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/15/2016141,009
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/15/20164,875
FITZGERALD EDWARD MExecutive VP, CFO03/03/201658,866
BERSTEIN DAVID LSVP, Chief IP Counsel03/03/201658,887
Duvall Martin JEVP, CCO03/03/201658,863
Cantor Maria ESVP, Corporate Affairs03/03/201658,869
CLACKSON TIMOTHY PPresident, R&D, CSO03/02/2016150,282
CLACKSON TIMOTHY PPresident, R&D, CSO03/03/201658,867
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/03/201658,852
Haluska FrankSVP, Clinical R&D, CMO03/03/201664,733
Panayiotopoulos ParisPresident and CEO02/01/2016299,996
Duvall Martin JEVP, CCO02/01/201670,578
CLACKSON TIMOTHY PPresident, R&D, CSO02/01/201670,517
Bollag Daniel MSr. VP, Reg. Affairs & Quality02/01/201670,548
Haluska FrankSVP, Clinical R&D, CMO02/01/201677,587
BERSTEIN DAVID LSVP, Chief IP Counsel02/01/201670,515
FITZGERALD EDWARD MExecutive VP, CFO02/01/201670,515
Cantor Maria ESVP, Corporate Affairs02/01/201677,745
BERGER HARVEY J M DChairman & CEO12/31/20151,777,381
BERSTEIN DAVID LSVP, Chief IP Counsel09/28/201532,315
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/28/201532,315
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/28/201532,315
Duvall Martin JEVP, CCO09/28/201532,317
Cantor Maria ESVP, Corporate Affairs09/28/201532,327
FITZGERALD EDWARD MExecutive VP, CFO09/28/201556,551
Haluska FrankSVP, Clinical R&D, CMO09/28/201535,502
CLACKSON TIMOTHY PPresident, R&D, CSO09/28/201556,560
BERSTEIN DAVID LSVP, Chief IP Counsel09/28/201532,315
Cantor Maria ESVP, Corporate Affairs09/01/201524,557
FITZGERALD EDWARD MExecutive VP, CFO08/28/2015328,580
Cantor Maria ESVP, Corporate Affairs08/28/201512,680
CLACKSON TIMOTHY PPresident, R&D, CSO07/16/201559,797
Duvall Martin JEVP, CCO07/16/201511,956
FITZGERALD EDWARD MExecutive VP, CFO07/16/201559,793
Bollag Daniel MSr. VP, Reg. Affairs & Quality07/16/201534,164
Cantor Maria ESVP, Corporate Affairs07/16/201534,162
BERSTEIN DAVID LSVP, Chief IP Counsel07/16/201534,162
Haluska FrankSVP, Clinical R&D, CMO07/16/201537,575
BERGER HARVEY J M DChairman & CEO07/15/2015145,040
FITZGERALD EDWARD MExecutive VP, CFO05/01/2015453,600
FITZGERALD EDWARD MExecutive VP, CFO05/01/2015528,000
CLACKSON TIMOTHY PPresident, R&D, CSO04/23/20151,175,777
BERGER HARVEY J M DChairman & CEO03/26/20151,039,175
BERGER HARVEY J M DChairman & CEO03/26/20151,134,000
BERSTEIN DAVID LSVP, Chief IP Counsel03/23/201517,118
BERSTEIN DAVID LSVP, Chief IP Counsel03/20/201521,026
Cantor Maria ESVP, Corporate Affairs and HR03/19/201524,255
Cantor Maria ESVP, Corporate Affairs and HR03/23/201534,491
Cantor Maria ESVP, Corporate Affairs and HR03/20/201531,627
Cantor Maria ESVP, Corporate Affairs and HR03/19/201584,114
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/23/201525,661
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/20/201535,390
FITZGERALD EDWARD MExecutive VP, CFO03/23/201535,630
FITZGERALD EDWARD MExecutive VP, CFO03/20/201547,908
Duvall Martin JEVP, CCO03/23/20157,145
Duvall Martin JEVP, CCO03/20/201535,381
Haluska FrankSVP, Clinical R&D, CMO03/23/201528,229
Haluska FrankSVP, Clinical R&D, CMO03/20/201531,634
CLACKSON TIMOTHY PPresident, R&D, CSO03/19/2015156,167
CLACKSON TIMOTHY PPresident, R&D, CSO03/19/2015185,913
CLACKSON TIMOTHY PPresident, R&D, CSO03/23/201557,016
CLACKSON TIMOTHY PPresident, R&D, CSO03/20/201547,910
BERSTEIN DAVID LSVP, Chief IP Counsel03/23/201517,118
BERSTEIN DAVID LSVP, Chief IP Counsel03/20/201521,026
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/16/20159,750
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/16/2015296,651
CLACKSON TIMOTHY PPresident, R&D, CSO02/20/2015173,419
CLACKSON TIMOTHY PPresident, R&D, CSO02/20/2015392,280
BERGER HARVEY J M DChairman & CEO02/12/201586,280
BERGER HARVEY J M DChairman & CEO02/11/201584,569
Haluska FrankSVP, Clinical R&D, CMO02/02/2015102,107
Cantor Maria ESVP, Corporate Affairs and HR02/02/2015102,089
Bollag Daniel MSr. VP, Reg. Affairs & Quality02/02/201592,823
CLACKSON TIMOTHY PPresident, R&D, CSO02/02/201592,820
Duvall Martin JEVP, CCO02/02/201592,823
FITZGERALD EDWARD MExecutive VP, CFO02/02/201592,849
BERSTEIN DAVID LSVP, Chief IP Counsel02/02/201592,826
BERGER HARVEY J M DChairman & CEO01/23/201577,250
BERGER HARVEY J M DChairman & CEO01/22/201576,990
Schlesinger Sarah J.Director01/13/20159,061
Schlesinger Sarah J.Director01/14/20158,125
BERGER HARVEY J M DChairman & CEO12/18/201481,770
BERGER HARVEY J M DChairman & CEO12/17/201476,875
Schlesinger Sarah J.Director12/17/20147,943
Schlesinger Sarah J.Director12/16/20147,891
Cantor Maria ESVP, Corporate Affairs and HR11/24/201412,243
BERGER HARVEY J M DChairman & CEO11/20/201476,889
BERGER HARVEY J M DChairman & CEO11/19/201476,853
Schlesinger Sarah J.Director11/12/20148,086
Schlesinger Sarah J.Director11/11/20148,190
BERGER HARVEY J M DChairman & CEO10/16/201467,317
BERGER HARVEY J M DChairman & CEO10/15/201463,727
Schlesinger Sarah J.Director10/15/20146,539
Schlesinger Sarah J.Director10/14/20146,591
BERGER HARVEY J M DChairman & CEO09/03/201478,859
BERGER HARVEY J M DChairman & CEO09/02/201477,777
BERSTEIN DAVID LSVP, GC and Chief IP Officer09/09/201440,929
BERSTEIN DAVID LSVP, GC and Chief IP Officer09/09/201440,925
BERGER HARVEY J M DChairman & CEO09/09/2014716,525
BERGER HARVEY J M DChairman & CEO09/09/2014784,500
BERGER HARVEY J M DChairman & CEO09/03/201478,859
BERGER HARVEY J M DChairman & CEO09/02/201477,777
Schlesinger Sarah J.Director08/13/20147,423
Schlesinger Sarah J.Director08/12/20147,176
Schlesinger Sarah J.Director09/10/20147,475
Schlesinger Sarah J.Director09/09/20147,709
FITZGERALD EDWARD MExecutive VP, CFO09/02/2014261,500
FITZGERALD EDWARD MExecutive VP, CFO09/02/2014310,835
Cantor Maria ESVP, Corporate Affairs and HR09/02/201416,753
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/02/201434,125
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/02/2014352,227
DENNER ALEXANDER JDirector08/15/20143,588,167
DENNER ALEXANDER JDirector08/15/20141,367,333
BERSTEIN DAVID LSVP, GC and Chief IP Officer07/15/201414,527
Bollag Daniel MSr. VP, Reg. Affairs & Quality07/15/201414,527
Cantor Maria ESVP, Corporate Affairs and HR07/15/201414,527
CLACKSON TIMOTHY PPresident, R&D, CSO07/15/201425,421
Haluska FrankSVP, Clinical R&D, CMO07/15/201414,527
FITZGERALD EDWARD MExecutive VP, CFO07/15/201425,421
BERGER HARVEY J M DChairman & CEO07/15/201486,647
Duvall Martin JEVP, CCO07/15/20145,085
Cantor Maria ESVP, Corporate Affairs and HR06/02/201425,611
Haluska FrankSVP, Clinical R&D, CMO04/02/201427,916
BERSTEIN DAVID LSVP, GC and Chief IP Officer04/02/201419,718
Bollag Daniel MSr. VP, Reg. Affairs & Quality04/02/201419,720
FITZGERALD EDWARD MExecutive VP, CFO04/01/201436,108
BERGER HARVEY J M DChairman & CEO04/01/2014115,736
Cantor Maria ESVP, Corporate Affairs and HR04/02/201434,907
CLACKSON TIMOTHY PPresident, R&D, CSO04/02/201453,337
Cantor Maria ESVP, Corporate Affairs and HR03/19/201416,880
Cantor Maria ESVP, Corporate Affairs and HR03/21/201428,930
BERSTEIN DAVID LSVP, GC and Chief IP Officer03/19/201412,334
BERSTEIN DAVID LSVP, GC and Chief IP Officer03/21/201412,630
Haluska FrankSVP, Clinical R&D, CMO03/19/201416,880
Haluska FrankSVP, Clinical R&D, CMO03/21/201418,941
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/19/201420,770
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/21/201418,936
CLACKSON TIMOTHY PPresident, R&D, CSO03/19/201428,190
CLACKSON TIMOTHY PPresident, R&D, CSO03/21/201452,583
Duvall Martin JEVP, CCO03/20/20144,301
Duvall Martin JEVP, CCO03/19/201421,441
FITZGERALD EDWARD MExecutive VP, CFO03/19/201428,133
FITZGERALD EDWARD MExecutive VP, CFO03/20/201422,089
BERGER HARVEY J M DChairman & CEO03/20/201490,113
BERGER HARVEY J M DChairman & CEO03/19/201495,913
CLACKSON TIMOTHY PPresident, R&D, CSO12/19/201350,115
Bollag Daniel MSr. VP, Reg. Affairs & Quality12/19/201318,528
Cantor Maria ESVP, Corporate Affairs12/19/201332,767
BERGER HARVEY J M DChairman & CEO12/18/2013146,910
Haluska FrankSVP, Clinical R&D, CMO12/19/201326,214
BERSTEIN DAVID LSenior VP, Chief IP Officer12/19/201323,130
Duvall Martin JSVP, Commercial Operations09/19/2013234,628
CLACKSON TIMOTHY PPresident, R&D, CSO09/06/2013185,878
FITZGERALD EDWARD MExecutive VP, CFO08/15/2013350,284
FITZGERALD EDWARD MExecutive VP, CFO08/15/2013128,700
BERGER HARVEY J M DChairman & CEO08/13/2013905,555
BERGER HARVEY J M DChairman & CEO08/14/201357,999
BERGER HARVEY J M DChairman & CEO08/14/20131,164,335
BERGER HARVEY J M DChairman & CEO08/13/201349,570
Bollag Daniel MSr. VP, Reg. Affairs & Quality07/18/2013126,639
BERSTEIN DAVID LSenior VP, Chief IP Officer07/18/2013158,290
Haluska FrankSVP, Clinical R&D, CMO07/18/2013126,642
DODION PIERRE FSVP, Corp. Dev. & Operations07/18/2013126,655
Keane Raymond TSVP General Counsel & CCO07/18/2013158,286
CLACKSON TIMOTHY PPresident, R&D, CSO07/18/2013277,045
Cantor Maria ESVP, Corporate Affairs07/18/2013158,299
BERGER HARVEY J M DChairman & CEO07/17/201352,912
BERGER HARVEY J M DChairman & CEO07/17/2013980,705
BERGER HARVEY J M DChairman & CEO07/16/201356,623
BERGER HARVEY J M DChairman & CEO07/16/20132,866,478
BERGER HARVEY J M DChairman & CEO07/15/2013729,600
FITZGERALD EDWARD MExecutive VP, CFO07/15/2013277,565
BERGER HARVEY J M DChairman & CEO06/19/2013104,415
BERGER HARVEY J M DChairman & CEO06/19/201397,208
BERGER HARVEY J M DChairman & CEO05/15/201348,983
BERGER HARVEY J M DChairman & CEO05/15/2013675,970
BERGER HARVEY J M DChairman & CEO05/14/201348,600
BERGER HARVEY J M DChairman & CEO05/14/2013900,295
BERGER HARVEY J M DChairman & CEO04/17/201397,201
BERGER HARVEY J M DChairman & CEO04/17/20131,800,590
Keane Raymond TSVP General Counsel & CCO04/02/201346,625
Haluska FrankSVP, Clinical R&D, CMO04/02/201361,339
Cantor Maria ESVP, Corporate Affairs04/02/201376,665
CLACKSON TIMOTHY PPresident, R&D, CSO04/02/2013117,245
DODION PIERRE FSVP, Corp. Dev. & Operations04/02/201343,295
BERGER HARVEY J M DChairman & CEO04/01/2013360,290
BERSTEIN DAVID LSenior VP, Chief IP Officer04/02/201343,322
FITZGERALD EDWARD MExecutive VP, CFO03/26/2013242,492
Keane Raymond TSVP General Counsel & CCO03/25/2013248,482
DODION PIERRE FSVP, Corp. Dev. & Operations03/25/2013153,482
BERSTEIN DAVID LSenior VP, Chief IP Officer03/25/2013198,807
Haluska FrankSVP, Clinical R&D, CMO03/25/2013100,672
CLACKSON TIMOTHY PPresident, R&D, CSO03/25/2013361,766
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/25/2013244,079
Cantor Maria ESVP, Corporate Affairs03/22/2013113,896
BERGER HARVEY J M DChairman & CEO03/22/2013894,348
BERGER HARVEY J M DChairman & CEO03/20/2013328,529
FITZGERALD EDWARD MExecutive VP, CFO03/20/201355,665
Duvall Martin JSVP, Commercial Operations03/22/201311,249
Keane Raymond TSVP General Counsel & CCO03/22/201345,423
DODION PIERRE FSVP, Corp. Dev. & Operations03/22/201346,698
Haluska FrankSVP, Clinical R&D, CMO03/22/201346,694
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/22/201346,694
BERSTEIN DAVID LSenior VP, Chief IP Officer03/22/201331,135
CLACKSON TIMOTHY PPresident, R&D, CSO03/22/2013129,718
Cantor Maria ESVP, Corporate Affairs03/22/201371,335
BERGER HARVEY J M DChairman & CEO03/13/20131,102,990
BERGER HARVEY J M DChairman & CEO03/13/201359,587
BERGER HARVEY J M DChairman & CEO03/12/20131,101,755
BERGER HARVEY J M DChairman & CEO03/12/201359,516
Cantor Maria ESVP, Corporate Affairs03/12/201346,310
CLACKSON TIMOTHY PPresident, R&D, CSO03/04/2013206,598
CLACKSON TIMOTHY PPresident, R&D, CSO01/15/2013292,414
FITZGERALD EDWARD MExecutive VP, CFO01/02/2013501,890
LAVIDAS ATHANESEDirector12/21/2012213,209
CLACKSON TIMOTHY PPresident, R&D, CSO12/20/2012141,210
Bollag Daniel MSr. VP, Reg. Affairs & Quality12/18/201275,836
Cantor Maria ESVP, Corporate Affairs12/18/2012107,438
CLACKSON TIMOTHY PPresident, R&D, CSO12/18/2012164,306
FITZGERALD EDWARD MExecutive VP, CFO12/18/2012164,306
Haluska FrankSVP, Clinical R&D, CMO12/18/2012107,438
DODION PIERRE FSVP, Corp. Dev. & Operations12/18/201275,836
BERSTEIN DAVID LSenior VP, Chief IP Officer12/18/201275,836
BERGER HARVEY J M DChairman & CEO12/18/2012526,577
Keane Raymond TSVP General Counsel & CCO12/18/201265,302
LAMARCHE JAY RDirector10/01/2012249,932
Bollag Daniel MSr. VP, Reg. Affairs & Quality10/01/20129,750
Bollag Daniel MSr. VP, Reg. Affairs & Quality10/01/2012187,500
FITZGERALD EDWARD MExecutive VP, CFO10/01/2012604,187
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/19/20129,750
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/19/2012180,000
BERSTEIN DAVID LSenior VP, Chief IP Officer09/19/201259,491
BERSTEIN DAVID LSenior VP, Chief IP Officer09/19/2012465,000
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/11/20129,750
Bollag Daniel MSr. VP, Reg. Affairs & Quality09/11/2012172,500
BERSTEIN DAVID LSenior VP, Chief IP Officer09/11/201259,491
BERSTEIN DAVID LSenior VP, Chief IP Officer09/11/2012445,625
BERSTEIN DAVID LSenior VP, Chief IP Officer09/11/201259,491
BERSTEIN DAVID LSenior VP, Chief IP Officer09/11/2012445,625
LAMARCHE JAY RDirector09/06/201239,900
LAMARCHE JAY RDirector09/06/201239,900
Keane Raymond TSVP General Counsel & CCO09/06/201223,900
Keane Raymond TSVP General Counsel & CCO09/06/2012220,000
BERSTEIN DAVID LSenior VP, Chief IP Officer09/06/201259,491
BERSTEIN DAVID LSenior VP, Chief IP Officer09/06/2012426,250
Keane Raymond TSVP General Counsel & CCO09/04/2012163,380
BERSTEIN DAVID LSenior VP, Chief IP Officer09/04/201242,102
BERSTEIN DAVID LSenior VP, Chief IP Officer09/04/2012337,050
CLACKSON TIMOTHY PPresident, R&D, CSO08/30/201232,503
LAMARCHE JAY RDirector08/15/2012400,032
Keane Raymond TSVP General Counsel & CCO08/15/201223,900
Keane Raymond TSVP General Counsel & CCO08/15/2012200,000
CLACKSON TIMOTHY PPresident, R&D, CSO08/15/2012278,533
CLACKSON TIMOTHY PPresident, R&D, CSO08/15/2012736,860
BERSTEIN DAVID LSenior VP, Chief IP Officer08/15/2012160,000
DODION PIERRE FSVP, Corp. Dev. & Operations07/30/2012137,250
DODION PIERRE FSVP, Corp. Dev. & Operations07/30/2012543,400
BERSTEIN DAVID LSenior VP, Chief IP Officer07/30/2012152,000
CLACKSON TIMOTHY PPresident, R&D, CSO07/30/2012121,514
CLACKSON TIMOTHY PPresident, R&D, CSO07/30/2012441,446
Keane Raymond TSVP General Counsel & CCO07/30/2012190,000
Bollag Daniel MSr. VP, Reg. Affairs & Quality07/30/20129,750
Bollag Daniel MSr. VP, Reg. Affairs & Quality07/30/2012142,500
Cantor Maria ESVP, Corporate Affairs07/30/201250,658
Cantor Maria ESVP, Corporate Affairs07/30/2012123,082
Keane Raymond TSVP General Counsel & CCO07/26/201223,900
Keane Raymond TSVP General Counsel & CCO07/26/2012180,000
LAVIDAS ATHANESEDirector07/20/201289,977
FITZGERALD EDWARD MExecutive VP, CFO07/02/2012440,950
Cantor Maria ESVP, Corporate Affairs06/25/201230,199
Bollag Daniel MSr. VP, Reg. Affairs & Quality06/22/20129,750
Bollag Daniel MSr. VP, Reg. Affairs & Quality06/22/2012131,269
LAVIDAS ATHANESEDirector06/20/201287,028
Cantor Maria ESVP, Corporate Affairs06/19/201223,100
Cantor Maria ESVP, Corporate Affairs06/19/2012135,000
BERGER HARVEY J M DChairman & CEO06/13/201299,984
BERGER HARVEY J M DChairman & CEO06/13/201299,999
LAVIDAS ATHANESEDirector06/05/2012159,750
LAVIDAS ATHANESEDirector06/05/2012401,280
BERSTEIN DAVID LSenior VP, Chief IP Officer05/21/2012109,254
BERSTEIN DAVID LSenior VP, Chief IP Officer03/26/2012128,000
BERSTEIN DAVID LSenior VP, Chief IP Officer05/21/2012431,398
LAVIDAS ATHANESEDirector05/21/201282,690
DODION PIERRE FSVP, Corp. Dev. & Operations05/16/2012387,275
FITZGERALD EDWARD MExecutive VP, CFO05/03/2012277,800
CLACKSON TIMOTHY PPresident, R&D, CSO05/02/2012148,800
CLACKSON TIMOTHY PPresident, R&D, CSO05/02/2012340,000
Haluska FrankSVP, Clinical R&D, CMO05/02/20127,170
Haluska FrankSVP, Clinical R&D, CMO05/02/201251,000
BERSTEIN DAVID LSenior VP, Chief IP Officer05/02/201247,661
BERSTEIN DAVID LSenior VP, Chief IP Officer05/02/2012329,375
LAVIDAS ATHANESEDirector04/20/2012150,558
FITZGERALD EDWARD MExecutive VP, CFO04/17/2012185,200
FITZGERALD EDWARD MExecutive VP, CFO04/17/2012600,000
CLACKSON TIMOTHY PPresident, R&D, CSO04/17/2012106,665
CLACKSON TIMOTHY PPresident, R&D, CSO04/13/2012468,628
DODION PIERRE FSVP, Corp. Dev. & Operations04/12/2012262,576
LAVIDAS ATHANESEDirector04/09/2012236,350
DODION PIERRE FSVP, Corp. Dev. & Operations04/02/201283,416
DODION PIERRE FSVP, Corp. Dev. & Operations04/02/2012171,887
Cantor Maria ESVP, Corporate Affairs04/03/201255,027
CLACKSON TIMOTHY PPresident, R&D, CSO04/03/201284,134
CLACKSON TIMOTHY PPresident, R&D, CSO03/26/2012425,876
BERSTEIN DAVID LSenior VP, Chief IP Officer04/03/201238,844
Keane Raymond TSVP General Counsel & CCO04/03/201233,455
FITZGERALD EDWARD MExecutive VP, CFO04/03/201284,156
BERGER HARVEY J M DChairman & CEO04/02/2012282,337
Bollag Daniel MSr. VP, Reg. Affairs & Quality04/02/201230,918
Haluska FrankSVP, Clinical R&D, CMO04/03/201268,767
DODION PIERRE FSVP, Corp. Dev. & Operations04/03/201238,836
CLACKSON TIMOTHY PPresident, R&D, CSO03/26/201247,925
CLACKSON TIMOTHY PPresident, R&D, CSO03/26/2012120,000
BERSTEIN DAVID LSenior VP, Chief IP Officer03/26/201247,661
BERSTEIN DAVID LSenior VP, Chief IP Officer03/26/2012182,000
DODION PIERRE FSVP, Corp. Dev. & Operations03/26/2012137,250
DODION PIERRE FSVP, Corp. Dev. & Operations03/26/2012412,500
Cantor Maria ESVP, Corporate Affairs03/26/201218,480
Cantor Maria ESVP, Corporate Affairs03/27/2012292,138
Cantor Maria ESVP, Corporate Affairs03/26/201296,000
Haluska FrankSVP, Clinical R&D, CMO03/26/20127,170
Haluska FrankSVP, Clinical R&D, CMO03/26/201248,000
Haluska FrankSVP, Clinical R&D, CMO03/23/2012102,718
Keane Raymond TSVP General Counsel & CCO03/23/2012162,271
DODION PIERRE FSVP, Corp. Dev. & Operations03/23/2012380,712
FITZGERALD EDWARD MExecutive VP, CFO03/23/2012199,239
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/22/2012162,178
BERGER HARVEY J M DChairman & CEO03/22/2012639,368
CLACKSON TIMOTHY PPresident, R&D, CSO03/23/2012236,211
BERSTEIN DAVID LSenior VP, Chief IP Officer03/23/2012162,274
BERGER HARVEY J M DChairman & CEO03/20/2012157,092
BERSTEIN DAVID LSenior VP, Chief IP Officer03/20/2012282,314
Keane Raymond TSVP General Counsel & CCO03/20/2012126,155
Haluska FrankSVP, Clinical R&D, CMO03/20/2012225,240
FITZGERALD EDWARD MExecutive VP, CFO03/20/2012468,605
DODION PIERRE FSVP, Corp. Dev. & Operations03/20/2012194,799
CLACKSON TIMOTHY PPresident, R&D, CSO03/20/2012546,622
Cantor Maria ESVP, Corporate Affairs03/20/2012210,218
CLACKSON TIMOTHY PPresident, R&D, CSO03/16/201262,192
BERGER HARVEY J M DChairman & CEO03/10/2012998,660
LAMARCHE JAY RDirector02/28/201288,800
BERSTEIN DAVID LSenior VP, Chief IP Officer02/28/201244,703
BERSTEIN DAVID LSenior VP, Chief IP Officer02/28/2012176,313
DODION PIERRE FSVP, Corp. Dev. & Operations02/23/2012137,250
DODION PIERRE FSVP, Corp. Dev. & Operations02/23/2012375,000
BERSTEIN DAVID LSenior VP, Chief IP Officer02/23/201261,500
Haluska FrankSVP, Clinical R&D, CMO02/21/201210,755
Haluska FrankSVP, Clinical R&D, CMO02/21/201265,277
BERSTEIN DAVID LSenior VP, Chief IP Officer02/21/201288,920
BERSTEIN DAVID LSenior VP, Chief IP Officer02/21/2012509,032
BERGER HARVEY J M DChairman & CEO02/15/2012344,826
CLACKSON TIMOTHY PPresident, R&D, CSO02/14/201264,350
CLACKSON TIMOTHY PPresident, R&D, CSO02/14/2012255,750
CLACKSON TIMOTHY PPresident, R&D, CSO02/14/2012312,908
CLACKSON TIMOTHY PPresident, R&D, CSO02/14/20121,155,781
Keane Raymond TSVP General Counsel & CCO02/14/201216,250
Keane Raymond TSVP General Counsel & CCO02/14/2012189,178
LAMARCHE JAY RDirector01/27/2012404,974
LAMARCHE JAY RDirector01/26/201246,627
BERGER HARVEY J M DChairman & CEO07/26/2011100,018
CLACKSON TIMOTHY PPresident, R&D, CSO06/07/2011378,576
CLACKSON TIMOTHY PPresident, R&D, CSO06/07/2011339,000
BERSTEIN DAVID LSenior VP, Chief IP Officer06/07/2011381,854
BERSTEIN DAVID LSenior VP, Chief IP Officer06/07/2011339,000
LAMARCHE JAY RDirector05/09/2011141,241
LAMARCHE JAY RDirector05/09/2011141,250
DODION PIERRE FSenior VP, Corp. Development04/11/201161,599
Bollag Daniel MSr. VP, Reg. Affairs & Quality04/11/2011123,190
CLACKSON TIMOTHY PPresident, R&D, CSO04/11/2011103,123
BERSTEIN DAVID LSenior VP, Chief IP Officer04/11/201154,204
FITZGERALD EDWARD MExecutive VP, CFO04/11/201178,120
LAMARCHE JAY RDirector03/25/2011175,277
Keane Raymond TSVP General Counsel & CCO03/22/201154,660
Haluska FrankVP, Clinical R&D, CMO03/22/201128,116
DODION PIERRE FSenior VP, Corp. Development03/22/201142,276
CLACKSON TIMOTHY PPresident, R&D, CSO03/22/201178,424
Bollag Daniel MSr. VP, Reg. Affairs & Quality03/22/201166,769
BERSTEIN DAVID LSenior VP, Chief IP Officer03/22/201154,373
LAMARCHE JAY RDirector02/02/2011161,925
LAMARCHE JAY RDirector01/11/2011137,675
LAMARCHE JAY RDirector01/11/2011137,388
LAMARCHE JAY RDirector12/20/2010125,006
Bollag Daniel MSr. VP, Reg. Affairs & Quality10/26/201011,100
CLACKSON TIMOTHY PPres., R & D., Chief Sci. Off.10/26/201037,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...